Medicine & Health

Researchers at Washington University School of Medicine have shown that an experimental nanoparticle-based drug therapy protects mice from sudden death due to the rupture of a major blood vessel in the abdomen, pointing the way toward a new strategy for treating deadly abdominal aortic aneurysms.

The National Institutes of Health (NIH) has awarded a five-year $1.67 million grant to Chuan Wang, assistant professor at the McKelvey School of Engineering, for research on preterm birth. Wang and an interdisciplinary team will develop soft sensors with stretchable electrodes to generate 3D maps of the uterine surface and better understand contractions.

The McKelvey School of Engineering’s Hong Chen and her team are developing tiny sensors to detect blast-induced traumatic brain injury with new funding from the Office of Naval Research.

The Tracy Family SILQ Center for Neurodegenerative Biology has been established at the School of Medicine. The center aims to help researchers discover, study and validate biomarkers of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, with a goal of identifying new drug targets and creating better diagnostic and prognostic tests.

A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

A new study from researchers at Washington University School of Medicine and colleagues at other institutions details a new tool that can quickly identify the presence of Ebola virus in blood samples. The technology has potential to be developed into a rapid diagnostic test.

Polina V. Lishko, a noted molecular biologist and entrepreneur, has been named a BJC Investigator at Washington University School of Medicine.

Antibiotics inappropriately prescribed to children resulted in at least $74 million in excess health-care costs in the U.S. in 2017, according to a new study from Washington University School of Medicine and The Pew Charitable Trusts.

Vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System.

Researchers at Washington University School of Medicine and the University of Wisconsin–Madison identified the genetic causes of three mitochondrial diseases by figuring out what dozens of poorly understood mitochondrial proteins do.